In terms of functional in vitro assays, authors reported an increase of phagocytosis capability of M2-BMDM MPEI/pCAR-IFN-γ treated cells for distinct ratios of BMDM: ALK+ target Neuro-2a tumor cell. The gene discussed is ALK; the disease is neoplasm.